Pharmacokinetics of Pavaverine After Intraluminal Administration

The purpose of this study is to determine the pharmacokinetic of papaverine after administration into the artery mammaria interna.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Injury of Internal Mammary Artery Complications Due to Coronary Artery Bypass Graft

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Klinikum der Goethe Universität Frankfurt

Frankfurt am Main, Hesse, 60590, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

CABG
Administration of papaverine into mammaria interna

Exclusion criteria

Allergy against papaverine

Treatment and study plan

CABG

Procedure

Preparation of artery mammaria interna

Other names: Paveron N

Primary outcomes

Maximum plasma concentration of papaverine

Time frame: 4 hours

Serum probes will be analysed for the concentrations of papaverine.

Sponsors and collaborators

Lead sponsor

Johann Wolfgang Goethe University Hospital

Other

Collaborators

Klinikum Ludwigshafen

Registry information

Official study title

Observational Study on Papaverine During Cardiac Surgical Procedures

Important dates

Study start: 2012
Primary completion: 2013
Study completion: 2013
First posted: Sep 20, 2011
Registry last updated: Jun 4, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed